2022年10月3日 · One type of MCV4, Menveo, is licensed for use in people ages 2 to 55. Another version, Menactra, is approved for those 9 months to 55 years old. MPSV4 is the only vaccine licensed for use in...

2024年10月24日 · There are 5 meningococcal vaccines available in the United States. Meningococcal vaccines help protect against one serogroup (strain) or multiple serogroups of the bacteria that cause meningococcal disease.

Schedule a meningitis vaccine at a CVS Pharmacy near you. Learn about what the meningococcal vaccine is, meningitis vaccine side effects and more.

2024年10月24日 · CDC recommends meningococcal vaccination for all adolescents. CDC also recommends meningococcal vaccination for children and adults at increased risk for meningococcal disease. Follow the recommended immunization schedule to ensure that your patients get the meningococcal vaccines that they need.

2024年2月6日 · Vaccines can help prevent meningococcal disease. There are 3 types of meningococcal vaccines available in the United States: All adolescents ages 11–12, with a booster dose at 16 years.

Currently, there are 6 meningococcal vaccines licensed and available in the United States. Learn about the composition, types, immunogenicity, and effectiveness of these vaccines, as well as view package inserts, below.

Meningococcal conjugate or MenACWY vaccines: The conjugate vaccine (MCV4, protecting against serogroups A, C, W, and Y) is preferred for people 9 months to 55 years old and is used for routine childhood vaccination (see CDC: Meningococcal ACWY …

2006年11月15日 · MCV4 should provide effective and longer-lasting immunity, but at significant expense to vaccinate the recommended target population. MCV4 is as effective and as safe as the older MPSV4.

Advisory Committee on Immunization Practices for the MCV4 = Menactra (sanofi) and Menveo (Novartis) MCV4-D = Menactra use of meningococcal vaccine. MCV4-CRM = Menveo Hib-MenCY = MenHibrix (GlaxoSmithKline) MPSV = Menomune (sanofi) If the person is HIV-positive, give 2 doses, 2 months apart.

The quadrivalent conjugate meningococcal vaccine is a routine childhood vaccination given to adolescents, preferably at age 11 or 12 years, with a booster dose at age 16 years (see CDC: Child and Adolescent Immunization Schedule by Age). It is also recommended for younger children who are at high risk of infection.